Balik M, Vignon P, Chew M S, Tavazzi G, Mayo P, Doufle G, Aron J, Hastings J, Cholley B, Jiroutkova K, Slama M, Herpain A, McLean A
First Faculty of Medicine, Department of Anesthesiology and Intensive Care, Charles University and General University Hospital, Prague, Czechia.
Medical-Surgical ICU and Inserm CIC 1435, Dupuytren Teaching Hospital, Limoges, France.
Intensive Care Med. 2025 Sep 17. doi: 10.1007/s00134-025-08112-8.
The growing burden of atrial fibrillation (AF) experienced by the general population translates into an increased incidence in the intensive care setting, further aggravated by illness severity. New onset AF has been established as an independent mortality predictor. Cardiology management guidelines are based on major trials that included ambulatory patients with varying degrees of ventricular systolic and diastolic dysfunction, and with variable dependences of left ventricular filling on atrial systole. Emphasis is placed on rate control combined with anticoagulation therapy, along with careful consideration of limiting any myocardial depression by antiarrhythmic medication in patients who often already have some form of structural heart disease.
Narrative review Objectives: Critical care echocardiography (CCE) is well established as a widely available diagnostic and monitoring tool in haemodynamically unstable patients. It assists in identifying risk factors associated with arrhythmias, reveals parameters associated with arrhythmia chronicity, and guides therapy to facilitate a return to sinus rhythm. CCE helps guide the crucial management decision to seek either rhythm or rate control and, with rhythm control, monitors return of mechanical sinus rhythm with left atrial recovery post cardioversion. Echocardiography can also help when conflicting management goals are present, such as guideline-driven therapeutic anticoagulation in the intensive care patient that is at significant risk of bleeding.
This review seeks to assist intensive care practitioners managing patients with AF, with a focus on the many benefits CCE offers, blending specific intensive care medicine data to current cardiology guidelines on arrhythmia management in these severely ill patients.
普通人群中心房颤动(AF)负担日益加重,这导致重症监护环境中的发病率上升,病情严重程度进一步加剧了这种情况。新发房颤已被确认为独立的死亡预测因素。心脏病管理指南基于主要试验,这些试验纳入了具有不同程度心室收缩和舒张功能障碍、左心室充盈对心房收缩依赖程度各异的门诊患者。重点在于心率控制联合抗凝治疗,同时在经常已有某种形式结构性心脏病的患者中,仔细考虑限制抗心律失常药物对心肌的抑制作用。
叙述性综述
重症监护超声心动图(CCE)已被广泛确立为血流动力学不稳定患者中广泛可用的诊断和监测工具。它有助于识别与心律失常相关的危险因素,揭示与心律失常慢性化相关的参数,并指导治疗以促进恢复窦性心律。CCE有助于指导寻求节律控制或心率控制这一关键管理决策,并且在节律控制时,监测机械性窦性心律的恢复以及复律后左心房的恢复情况。当存在相互冲突的管理目标时,例如在重症监护患者中遵循指南进行有显著出血风险的治疗性抗凝时,超声心动图也能提供帮助。
本综述旨在协助重症监护医生管理房颤患者,重点关注CCE所带来的诸多益处,将特定的重症监护医学数据与当前关于这些重症患者心律失常管理的心脏病学指南相结合。